A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough

NCT02993822 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

315

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Refractory Cough

Interventions

DRUG: Orvepitant Maleate
DRUG: Placebo

Sponsor

Nerre Therapeutics Ltd.